WASHINGTON — After a grueling, decadelong fight, President Trump last month signed a new law that aims to help lower drug prices — the first substantial piece of legislation on that issue that’s made it to his desk.

But the bill’s yearslong struggle to make it to the president’s desk highlights a jarring reality in Washington: Even when a drug pricing bill is relatively straightforward and bolstered by broad bipartisan support, even when hospitals, insurers, doctors and patient groups all back it, even when nearly everyone in Washington wants to lower drug prices, it takes years to get anything done. 

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Economics 101 is a simple concept , allow competition. Competition will lower prices. The problem
    is that there is a middleman that doesn’t let this happen. These middlemen are called PBM’s.
    PBM’s are, and will always be the reason for high drug prices. PBM’s have virtually NO laws that govern
    them. As long as PBM’s are free to do as they please without any consequences the fleecing of America will continue. They have one concern, their profits. Transparency is nonexistent , They actually claim
    that their hidden price schedule is proprietary ! I guess the Maffia should have used that bull shit line
    when the U.S Attorney locked them up for all the illegal activity they did!
    PBM’s are the wolf that watches the hen house. The sick thing about it is that they are getting away with it. The 3 biggest PBM’s control 85% of every prescription filled in this country, and they steal from every
    possible angle along the drug chain, from the manufacturer to the consumer. Now that D.O.J allowed
    Aetna,Cigna and Humana to buy the 3 largest PBM’s they have full vertical control of the health sistem.
    Yes ladies and gentleman WE ARE ALL SCREWED !!!!!!!

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy